Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
Last stage
Pre-seed
Investors
Nisha Gopal
Founder CSO at Abinitio Bio (YC P26). Biochemist with 14 years of experience, Stanford PhD, former research scientist at the The Broad Institute of Harvard and MIT
LinkedInDaniel Mukasa
PhD in Applied Physics and Materials Science from Caltech; Postdoctoral Fellow at MIT focused on AI and drug discovery; previously AI/ML intern at Merck on antibody therapeutic design; finalist for Alzheimer's Insights AI prize.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.
